Adia Med, Inc. (ADIA) stock

ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.13−0.01 (-7.14%)

Close on Oct 19, 2026Market cap $20.98MP/E –Yield –

Adia Med enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Adia Med's enterprise value was $12.04M on Oct 19, 2026, against $3.66M a year earlier.

Period	Period end	Value	Change
2026	Oct 19, 2026	$12.04M	+68.4%
2025	Dec 31, 2025	$7.15M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADIA.

Revenue growth10879.7% · median 4.2%

Gross margin27.4% · median 66.4%

Operating margin-52.3% · median -2180.9%

Net margin-56.5% · median -1932.8%

Advertisement
300 × 250

See a number that looks wrong?